• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconVaccines

Vaccines

Page 24 of 31
Coronavirus
Health
The science behind the leading COVID vaccines will lead to faster manufacturing
By Sy MukherjeeDecember 5, 2020
AstraZeneca COVID-19 vaccine comes under scrutiny again, this time in India
AstraZeneca COVID-19 vaccine comes under scrutiny again, this time in India
By Naomi Xu ElegantNovember 30, 2020
Biden’s national coronavirus strategy is starting to take shape—and it’s very different than Trump’s
Politics
Biden’s national coronavirus strategy is starting to take shape—and it’s very different than Trump’s
By The Associated Press and Lisa MascaroNovember 28, 2020
Bet on these stocks for the millennial-powered COVID recovery, says Goldman’s Katie Koch
Finance
Bet on these stocks for the millennial-powered COVID recovery, says Goldman’s Katie Koch
By Anne SradersNovember 28, 2020
Syringe shown against the AstraZeneca logo
Health
AstraZeneca eyes another global trial for its COVID vaccine following dosage blip
By Suzi Ring, James Paton and BloombergNovember 27, 2020
For AstraZeneca’s COVID vaccine, less may be more—and that’s puzzling researchers
Health
For AstraZeneca’s COVID vaccine, less may be more—and that’s puzzling researchers
By Angelica LaVito, John Lauerman and BloombergNovember 25, 2020
AstraZeneca says its Covid-19 vaccine is up to 90% effective
Health
AstraZeneca says its Covid-19 vaccine is up to 90% effective
By Jeremy KahnNovember 23, 2020
The vaccine jolt fades, sinking global stocks—except for this one surprising sector
Newsletters
The vaccine jolt fades, sinking global stocks—except for this one surprising sector
By Bernhard WarnerNovember 12, 2020
Picture of two syringes on a tray.
Health
U.K. to use A.I. to spot dangerous side effects in the millions of COVID-19 vaccinations it will deliver
By Jeremy KahnNovember 5, 2020
AstraZeneca-Oxford COVID vaccine on track for year end, CEO Pascal Soriot says
Health
AstraZeneca-Oxford COVID vaccine on track for year end, CEO Pascal Soriot says
By Suzi Ring, James Paton and BloombergNovember 5, 2020
COVID vaccine science
Health
The science behind the leading COVID vaccine candidates
By Sy MukherjeeNovember 3, 2020
CEO of Chinese drugmaker defends his COVID vaccine’s January 2022 timeline
Conferences
CEO of Chinese drugmaker defends his COVID vaccine’s January 2022 timeline
By Naomi Xu ElegantOctober 27, 2020
What will it take for Beijing to meet its climate goals? Changing how it governs entirely
Health
What will it take for Beijing to meet its climate goals? Changing how it governs entirely
By Grady McGregorOctober 22, 2020
A masked and gloved healthcare worker holding a syringe.
Health
U.K. drug trial will deliberately expose young people to coronavirus, despite ethical concerns
By Jeremy KahnOctober 21, 2020
J&J CEO still optimistic COVID-19 vaccine could come as early as this year
Health
J&J CEO still optimistic COVID-19 vaccine could come as early as this year
By Robert HackettOctober 14, 2020
1...
  • 22
  • 23
  • 24
  • 25
  • 26
...31
Most Popular
Success
MacKenzie Scott alone accounted for one-third of America's $19.2 billion in megagifts last yearplaceholder alt text
By Sydney LakeJune 25, 2026
Success
Philanthropy leader at Warren Buffett and Bill Gates’ Giving Pledge says children of billionaires are pushing them to give their wealth away fasterplaceholder alt text
By Preston ForeJune 27, 2026
Success
Elon Musk on MacKenzie Scott giving away $26 billion of her fortune: 'Sadly,' it makes the world a worse placeplaceholder alt text
By Sydney LakeJune 29, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.